000 01134 a2200349 4500
005 20250512212141.0
264 0 _c19841101
008 198411s 0 0 eng d
022 _a0093-7754
040 _aNLM
_beng
_cNLM
100 1 _aPrentice, H G
245 0 0 _aMitoxantrone in relapsed and refractory acute leukemia.
_h[electronic resource]
260 _bSeminars in oncology
_cSep 1984
300 _a32-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcute Disease
650 0 4 _aAged
650 0 4 _aAnthraquinones
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCell Line
650 0 4 _aClinical Trials as Topic
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aLeukemia
_xdrug therapy
650 0 4 _aLeukemia, Lymphoid
_xdrug therapy
650 0 4 _aLeukemia, Myeloid
_xdrug therapy
650 0 4 _aMitoxantrone
700 1 _aRobbins, G
700 1 _aMa, D D
700 1 _aHo, A D
773 0 _tSeminars in oncology
_gvol. 11
_gno. 3 Suppl 1
_gp. 32-5
999 _c6385164
_d6385164